Compare HAE & AVNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HAE | AVNT |
|---|---|---|
| Founded | 1971 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.4B |
| IPO Year | 1996 | 2000 |
| Metric | HAE | AVNT |
|---|---|---|
| Price | $105.01 | $43.69 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 5 |
| Target Price | ★ $84.13 | $41.50 |
| AVG Volume (30 Days) | 713.3K | ★ 835.6K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.04% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.72 | ★ 1.31 |
| Revenue | $910,373,000.00 | ★ $3,835,500,000.00 |
| Revenue This Year | N/A | $4.90 |
| Revenue Next Year | $5.23 | $3.48 |
| P/E Ratio | $125.38 | ★ $34.65 |
| Revenue Growth | N/A | ★ 1.71 |
| 52 Week Low | $47.32 | $27.48 |
| 52 Week High | $92.25 | $46.64 |
| Indicator | HAE | AVNT |
|---|---|---|
| Relative Strength Index (RSI) | 83.12 | 61.11 |
| Support Level | $79.52 | $35.32 |
| Resistance Level | N/A | $44.85 |
| Average True Range (ATR) | 3.10 | 1.52 |
| MACD | 1.15 | 0.44 |
| Stochastic Oscillator | 93.64 | 72.79 |
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two reportable segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The Color, Additives, and Inks segment and the distribution segment generate maximum revenue. Geographically, the company generates maximum revenue from the United States and Canada, followed by EMEA, Asia, and Latin America.